Supraflex Cruz evidence presented at TCT 2025
In November 2025, EUKON shared an update from Sahajanand Medical…
In November 2025, EUKON shared an update from Sahajanand Medical…
In January 2026, EUKON announced the first clinical use in…
EUKON announced the availability of Supraflex Cruz NEVO to Italian…
The AIR-STEMI trial was presented by Associate Professor Simone Biscaglia…
EUKON announced the first Hydra TAVI implantation in Puglia at…
EUKON and IMDS took part in the Hands-On Village at…
EUKON received the PulseCath Awards 2026 Innovation Partner Award ahead…
At EuroPCR 2026, Sahajanand Medical Technologies (SMT) presented EUKON with…
EUKON will join the 47th National Congress of GISE at…
Caserta, ITALY – August 8th, 2023 We are absolutely…
FT 1000: the sixth annual list of Europe’s fastest-growing companies…
Leader della Crescita is rank of first 450 companies, done…
EUKON and SMT present Next Generation PCI Symposia at GISE…
EUKON SMT present Innovations in Structural Heart Intervention PFO and TAVI…
FAVOR III China has bees published on Lancet and simultaneously…
Dr Stefano Galli Interventional Cardiologist at “Cardiologico Monzino” in Milan…
In this interview Dr Simone Biscaglia, S. Anna University in…
Caserta, ITALY – September 8th, 2021 — EUKON’ experience in…
Multicenter-clinical-evaluation-of-a-piezoresistive-MEMSsensor-rapid-exchange-pressure-microcatheter-system-for-fractional-flow-reserve-measurement-2021.pdf This multicenter, prospective clinical study investigates whether the…
Today dr Luigi di Serafino of University Federico II in…
The VULNERABLE PATIENT WHO is the vulnerable patient ? HOW…
On June 18th at 14:30 CET Live In The Box…
At EuroPCR 2021 TALENT 3yrs follow up has been presented.…
Physiology-guided PCI in MVD Chairman Prof. Emanuele Barbato and Dr…
11 March 2021 The PROSPECT II Study has been published…
On March 5th at 8:00 am ET (14:00 CET) presented…
February 5th(Fri.) 9:00-11:10 am (C.E.T.) Insight Lifetech Co., Ltd We…
It’s time of QFR the most innovative, accurate, easy and…
Claudia Mugnoz interviews Prof. Varbella and Dr. Cerrato “Evolution and…
After get approval from National Medical Products Admnistation and CE…
How can influence NIRS-IVUS of interventional cardiologists daily?
Watch video to discover how.
Roadmap to guarantee homogeneous access throughout the whole national territory…
Click here to see where do we stand?
The PROSPECT II study was presented as Late-Breaking Clinical Trials…
For read click on The PROSPECT ABSORB Study (Jacc 2020)